Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Gene Therapy for Wilson Disease With 64CuCl₂ PET Imaging

NCT07159581 is registered in ClinicalTrials.gov with Thomas Damgaard Sandahl as lead sponsor.

NCT NCT07159581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07159581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Gene Therapy for Wilson Disease With 64CuCl₂ PET Imaging
Lead sponsor
Thomas Damgaard Sandahl
Phase
Observational
Overall status
Enrolling by invitation
Start date
July 8, 2025
Completion date
January 31, 2026
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wilson disease